Literature DB >> 2831077

Platelets as models: use and limitations.

A Pletscher1.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2831077     DOI: 10.1007/BF01952200

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Increase of free 5-hydroxytryptamine in blood plasma by reserpine and a benzoquinolizine derivative.

Authors:  M K PAASONEN; A PLETSCHER
Journal:  Experientia       Date:  1959-12-15

2.  Release of blood platelet serotonin by reserpine and lack of effect on bleeding time.

Authors:  P A SHORE; A PLETSCHER; E G TOMICH; R KUNTZMAN; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1956-06       Impact factor: 4.030

3.  Serotonin as a mediator of reserpine action in brain.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1956-01       Impact factor: 4.030

4.  Ultrastructural localization of 5-hydroxytryptamine in blood platelets.

Authors:  J P Tranzer; M Da Prada; A Pletscher
Journal:  Nature       Date:  1966-12-31       Impact factor: 49.962

Review 5.  Release of 5-hydroxytryptamine from blood platelets.

Authors:  M K Paasonen
Journal:  J Pharm Pharmacol       Date:  1965-11       Impact factor: 3.765

Review 6.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

7.  Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle.

Authors:  M Knorr; R Locher; E Vogt; W Vetter; L H Block; F Ferracin; H Lefkovits; A Pletscher
Journal:  Eur J Biochem       Date:  1988-03-15

8.  Melatonin synthesis by rabbit platelets.

Authors:  J M Launay; B J Lamaître; H P Husson; C Dreux; L Hartmann; M Da Prada
Journal:  Life Sci       Date:  1982-10-04       Impact factor: 5.037

  8 in total
  12 in total

1.  Diurnal variations of whole blood serotonin content in patients with depression and neurosis.

Authors:  M H Pietraszek; T Urano; K Sumiyoshi; Y Takada; A Takada; K Ohara; N Kondo; K Ohara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Platelet monoamine oxidase B activity in parkinsonian patients.

Authors:  U Bonuccelli; P Piccini; P Del Dotto; G M Pacifici; G U Corsini; A Muratorio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

3.  Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients.

Authors:  P Bongioanni; M Donato; M Castagna; F Gemignani
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Mitochondrial DNA Sequence Variation Associated With Peripheral Nerve Function in the Elderly.

Authors:  Shana M Katzman; Elsa S Strotmeyer; Michael A Nalls; Yiqiang Zhao; Sean Mooney; Nik Schork; Anne B Newman; Tamara B Harris; Kristine Yaffe; Steven R Cummings; Yongmei Liu; Gregory J Tranah
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-13       Impact factor: 6.053

5.  Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets.

Authors:  Tatsuyuki Akimoto; Ichiro Kusumi; Katsuji Suzuki; Takuya Masui; Tsukasa Koyama
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

6.  Effect of mood stabilizing agents on agonist-induced calcium mobilization in human platelets.

Authors:  I Kusumi; T Koyama; I Yamashita
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

7.  Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.

Authors:  G Faludi; K Tekes; L Tóthfalusi
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

8.  Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.

Authors:  G A Jamieson; A K Agrawal; N J Greco; T E Tenner; G D Jones; K C Rice; A E Jacobson; J G White; N N Tandon
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 9.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

10.  Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.

Authors:  J C Pecknold; L Luthe; L Iny; D Ramdoyal
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.